Cephalexin
Product Images NDC 52959-030

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 52959-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (Cephalexin Figure 01)

Molecular Structure (Cephalexin Figure 01)
Chemical structure of the active ingredient Cephalexin, depicting the molecular framework including a beta-lactam ring, phenyl group, and other characteristic components.*
FDA Label Image

250 mg-100s Pack (Cephalexin Figure 02)

250 mg-100s Pack (Cephalexin Figure 02)
Cephalexin 250 mg capsules label shows the product strength and dosage form. It lists lot number CXL200ZL, manufactured by Lupin in India, with an expiration date of 08/08. The label references comparison to Keflex and describes the capsules as white body with dark green. It includes prescription restriction warnings and instructions to follow doctor directions. The label also displays multiple small red-bordered repeat labels with similar product details and lot information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.